KELLANOVA Cashflow Statement | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statement of cash flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 28, 2024	FY2023 12 months to Dec 30, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Jan 1, 2022	FY2020 12 months to Jan 2, 2021
Operating Activities
Net income
Adjustments to reconcile net income to operating cash flows
Depreciation and amortization
Impairment of property
Postretirement benefit plan expense (benefit)
Deferred income taxes
Stock compensation
Multi-employer pension plan exit liability
Gain from unconsolidated entities, net
Loss on Russia divestiture
Other
Postretirement benefit plan distributions

Tax payment related to divestitures
Postretirement benefit plan contributions
Changes in operating assets and liabilities, net of acquisitions and divestitures:
Trade receivables
Inventories
Accounts payable
All other current assets and liabilities
Net cash provided by (used in) operating activities

Investing activities
Additions to properties
Issuance of notes receivable
Repayments from notes receivable
Acquisitions, net of cash acquired
Divestiture, net of cash disposed
Purchases of marketable securities
Sales of marketable securities
Settlement of net investment hedges
Investments in unconsolidated entities
Acquisition of cost method investments
Purchases of available for sale securities
Sales of available for sale securities
Other
Net cash provided by (used in) investing activities

Financing activities
Net increase (reduction) of notes payable, with maturities less than or equal to 90 days
Issuances of notes payable, with maturities greater than 90 days
Reductions of notes payable, with maturities greater than 90 days
Issuances of long-term debt
Reductions of long-term debt
Debt redemption costs
Net issuances of common stock
Common stock repurchases
Cash dividends
Collateral received on derivative instruments
Proceeds received from debt issued and retained by WK Kellogg Co
Cash retained by WK Kellogg Co at separation
Other
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental cash flow disclosures:
Interest paid
Income taxes paid
Supplemental cash flow disclosures of non-cash investing activities:
Additions to properties included in accounts payable

Comments